ABSTRACI'. We studied the effects of short and long durations of insulin-induced maternal hypoglycemia upon in vivo glucose utilization of several fetal tissues in the rat. Osmotic minipumps filled with insulin were implanted in pregnant rats on d 15 or 18 of gestation (term 21.5 d), and radiolabeled 2-deoxyglucose was used to measure relative glucose utilization rates (rCU) of fetal liver, lung, muscle, kidney, heart, placenta, and brain on d 20 of gestation after 2 or 5 d of hypoglycemia. Maternal plasma glucose concentrations decreased within 24 h of pump placement and remained less than controls throughout gestation. Fetal plasma glucose and insulin concentrations on d 20 were equally reduced after 2 and 5 d of hypoglycemia. Both 2 and 5 d of hypoglycemia were associated with significant reductions in the rCU of fetal liver, lung, and muscle. Reductions in fetal kidney rCU also occurred after 2 and 5 d of hypoglycemia but to a smaller degree. rGU of fetal heart was reduced after 2 d of hypoglycemia, but was normal after 5 d of hypoglycemia. Both 2 and 5 d of hypoglycemia were associated with increased rCU of fetal brain. Five d, but not 2 d of hypoglycemia resulted in decreased fetal weight on d 20 of gestation. However, at term, newborn pups delivered of hypoglycemic mothers weighed significantly less than controls regardless of the timing of minipump placement. Liver, lung, and carcass of these growth-retarded pups weighed less than control tissues, whereas kidney, heart, and brain weights were not affected. We speculate that fetal tissue growth and glucose utilization are influenced by common mechanisms and that glucose utilization may be an important determinant of fetal tissue growth. (Pediatr Res 32: 436-440, 1992) Abbreviations rCU, relative glucose utilization IUGR, intrauterine growth retardation 2DG, 2-deoxyglucose 2DG6P, 2-deoxyglucose-6-phosphate Pk, placental discrimination constant IUGR is a frequently occurring obstetrical problem associated with an increased incidence of perinatal mortality and morbidity. Limited metabolic fuel availability to the fetus is an important factor in the development of IUGR. Decreased availability of maternally derived glucose is responsible for diminished plasma glucose and insulin concentrations in growth-retarded human fetuses (l,2). Fetal hypoglycemia and hypoinsulinemia, in turn, are major factors retarding fetal growth; glucose is a primary fetal metabolic substrate and insulin is a key growth-stimulating hormone that has mitogenic and numerous anabolic effects.The effects of limited glucose availability upon fetal growth is apparently tissue-specific because IUGR often results in asymmetric fetal growth, i.e. limited somatic but normal brain growth. The mechanisms for this phenomenon are not completely understood. Whether glucose utilization of specific tissues reflects these differential growth patterns under conditions of limited glucose availability is not known and is the focus of this study.We previously studied the effects of maternal uterine arter...